The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow

Genes and Development

Volumn 12, Issue 15, 1998, Pages 2392-2402

  Wang, Li Chun ^a,c   Swat, Wojciech ^a   Fujiwara, Yuko ^a,b   Davidson, Laurie ^a   Visvader, Jane ^a   Kuo, Frank ^a   Alt, Fred W ^a,b   Gilliland, D Gary ^a,b   Golub, Todd R ^a   Orkin, Stuart H ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c BIOGEN   (United States)

Author keywords

Hematopoiesis; Leukemia; TEL gene

Indexed keywords

TRANSCRIPTION FACTOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BONE MARROW; CELL DIFFERENTIATION; CELL PROLIFERATION; FETUS LIVER; GENE TARGETING; HEMATOPOIESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; YOLK SAC;

ANIMALIA;

EID: 0000418386     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.12.15.2392     Document Type: Article

References (44)

1. Arroyo, A., J.T. Yang, H. Rayburn, and R.O. Hynes. 1996. Differentiation requirement for α4 integrins during fetal and adult hematopoiesis. Cell 85: 997-1008.
2. Carroll, M., M.H. Thomasson, G.F. Barker, T.R. Golub, and D.G. Gilliland. 1996. The TEL/PDGFRβ fusion in CMML is a transforming protein that self-associates and activates PDGFRβ kinase-dependent signaling pathways. Proc. Natl. Acad. Sci. 93: 14845-14850.
3. Chen, J., R. Lansford, V. Stewart, F. Young, and F.W. Alt. 1993. RAG-2-deficient blastocyst complementation: An assay of gene function in lymphocyte development. Proc. Natl. Acad. Sci. 90: 4528-4532.
4. Coulombel, L., I. Auffray, M.H. Gaugler, and M. Rosenblatt. 1997. Expression and function of integrins on hematopoietic progenitor cells. Acta Haematol. 97: 13-21.
5. Delassus, S. and A. Cumano. 1996. Circulation of hematopoietic progenitors in the mouse embryo. Immunity 4: 97-106.
6. Ford, A.M., C.A. Bennett, C.M. Price, M.C.A. Bruin, E.R.V. Wering, and M. Greaves. 1998. Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. Proc. Natl. Acad. Sci. 95: 4584-4588.
7. Gale, K.B., A.M. Ford, R. Repp, A. Borkhardt, C. Keller, O.B. Eden, and M.F. Greaves. 1997. Backtracking leukemia to birth: Identification of clonotypic gene fusion sequences in neonatal blood spots. Proc. Natl. Acad. Sci. 94: 13950-13954.
8. Godin, I.E., J.A. Garcia-Porrero, A. Coutinho, F. Dieterlen-Lievre, and M.A.R. Marcos. 1993. Para-aortic splanchnopleura from early mouse embryos contains B1a cell progenitors. Nature 364: 67-70.
9. Golub, T.R., G.F. Barker, M. Lovett, and D.G. Gilliland. 1994. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77: 307-316.
10. Golub, T.R., G.F. Barker, S.K. Bohlander, S. Hiebert, D.C. Ward, P. Bray-Ward, E. Morgan, S.C. Raimondi, J.D. Rowley, and D.G. Gilliland. 1995. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. 92: 4917-4921.
11. Golub, T.R., A. Goga, G.F. Barker, D.E. Afar, J. McLaughlin, S.K. Bohlander, J.D. Rowley, O.N. Witte, and D.G. Gilliland. 1996. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia. Mol. Cell. Biol. 16: 4107-4116.
12. Golub, T.R., G.F. Barker, K. Stegmaier, and D.G. Gilliland. 1997. The TEL gene contributes to the pathogenesis of myeloid and lymphoid leukemias by diverse molecular genetic mechanisms. Curr. Top. Microbiol. Immunol. 220: 67-79.
13. Hirsch, E., A. Iglesias, A.J. Potocnik, U. Hartmann, and R. Fassler. 1996. Impaired migration but not differentiation of haematopoietic stem cells in the absence of β1 integrins. Nature 380: 171-175.
14. Hynes, R.O. 1996. Targeted mutations in cell adhesion genes: What have we learned from them? Dev. Biol. 180: 402-412.
15. Kennedy, M., M. Firpo, K. Choi, C. Wall, S. Robertson, N. Kabrun, and G. Keller. 1997. A common precursor for primitive erythropoiesis and definitive hematopoiesis. Nature 386: 488-493.
16. Kim, D.-H., R.L. Moldwin, C. Vignon, S.K. Bohlander, Y. Suto, L. Giordano, R. Gupta, S. Fears, G. Nucifora, J.D. Rowley, and S.D. Smith. 1996. TEL-AML1 translocations with TEL and CDKN2 inactivation in acute lymphoblastic leukemia cell lines. Blood 88: 785-794.
17. Lacronique, V., A. Boureux, V.D. Valle, H. Poirel, C.T. Quang, M. Mauchauffe, C. Berthou, M. Lessard, R. Berger, J. Ghysdael, and O.A. Bernard. 1997. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. Science 278: 1309-1312.
18. Mayani, H., L.J. Guilbert, and A. Jamowska-Wieczorek. 1992. Biology of the hematopoietic microenvironment. Eur. J. Haematol. 49: 225-233.
19. McLean, T.W., S. Ringold, D. Neuberg, K. Stegmaier, R. Tantravahi, J. Ritz, H.P. Koeffler, S. Takeuchi, J.W.G. Janssen, T. Seriu, C.R. Bartram, S.E. Sallan, D.G. Gilliland, and T.R. Golub. 1996. TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia. Blood 88: 4252-4258.
20. Medvinsky, A. and E. Dzierzak. 1996. Definitive hematopoiesis is autonomously initiated by the AGM region. Cell 86: 897-906.
21. Medvinsky, A.L., N.L. Samoylina, A.M. Muller, and E.A. Dzierzak. 1993. An early pre-liver intraembryonic source of CFU-S in the developing mouse. Nature 364: 64-66.
22. Nowell, P.C. 1976. The clonal evolution of tumor cell populations. Science 194: 23-28.
23. Okuda, T., J.v. Deursen, S.W. Hiebert, G. Grosveld, and J.R. Downing. 1996. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84: 321-330.
24. Orkin, S.H. 1996. Development of the hematopoietic system. Curr. Opin. Genet. Devel. 6: 597-602.
25. Papadopoulos, P., S.A. Ridge, C.A. Boucher, C. Stocking, and L.M. Wiedemann. 1995. The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res. 55: 34-38.
26. Papayannopoulou, T. and C. Craddock. 1997. Homing and trafficking of hemopoietic progenitor cells. Acta Haematol. 97: 97-104.
27. Peeters, P., S.D. Raynaud, J. Cools, I. Wlodarska, J. Grosgeorge, P. Philip, F. Monpoux, L.V. Rompaey, M. Baens, H.V. Berghe, and P. Marynen. 1997. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia. Blood 90: 2535-2540.
28. Pevny, L., M.C. Simon, E. Robertson, W.H. Klein, S.-F. Tsai, V. D'Agati, S.H. Orkin, and F. Costantini. 1991. Erythroid differentiation in chimeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349: 257-260.
29. Porcher, C., W. Swat, K. Rockwell, Y. Fujiwara, F.W. Alt, and S.H. Orkin. 1996. The T-cell leukemia oncoprotein SCL/ tal-1 is essential for development of all hematopoietic lineages. Cell 86: 47-57.
30. Rabbitts, T.H. 1994. Chromosomal translocations in human cancer. Nature 372: 143-149.
31. Raynaud, S., H. Cave, M. Baens, C. Bastard, V. Cacheux, J. Grosgeorge, C. Guidal-Giroux, C. Guo, E. Vilmer, P. Marynen, and B. Grandchamp. 1996. The 12;21 translocation involving TEL and deletion of the other TEL allele: Two frequently associated alterations found in childhood acute lymphoblastic leukemia. Blood 87: 2891-2899.
32. Robb, L., N.J. Elwood, A.G. Elefanty, F. Kontgen, R. Li, L.D. Barnett, and C.G. Begley. 1996. The sc1 gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J. 15: 4123-4129.
33. Romana, S.P., M. Mauchauffe, M. Le Coniat, I. Chumakov, D. Le Paslier, R. Berger, and O.A. Bernard. 1995. The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion. Blood 85: 3662-3670.
34. Sato, Y., Y. Suto, J. Pietenpol, T.R. Golub, D.G. Gilliland, E.M. Davis, M.M. Le Beau, J.M. Roberts, B. Vogelstein, J.D. Rowley, and S.K. Bohlander. 1995. TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies. Blood 86: 1525-1533.
35. Shivdasani, R.A. and S.H. Orkin. 1996. The transcriptional control of hematopoiesis. Blood 87: 4025-4039.
36. Shurtleff, S.A., A. Buijs, F.G. Behm, J.E. Rubnitz, S.C. Raimondi, M.L. Hancock, G.C. Chan, C.H. Pui, G. Grosveld, and J.R. Downing. 1995. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis. Leukemia 9: 1985-1989.
37. Stegmaier, K., S. Pendse, G.F. Barker, P. Bray-Ward, D.C. Ward, K.T. Montgomery, K.S. Krauter, C. Reynolds, J. Sklar, M. Donnelly, S.K. Bohlander, J.D. Rowley, S.E. Sallan, D.G. Gilliland, and T.R. Golub. 1995. Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood. Blood 86: 38-44.
38. Veiby, O.P., A.A. Mikhail, and H.R. Snodgrass. 1997. Growth factors and hematopoietic stem cells. Hematol. Oncol. Clin. N. Am. 11: 1173-1184.
39. Verfaillie, C.M. 1997. Stem cells in chronic myelogenous leukemia. Hematol. Oncol. Clin. N. Am. 11: 1079-1114.
40. Wang, Q., T. Stacy, M. Binder, M. Marin-Padilla, A.H. Sharpe, and N.A. Speck. 1996. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci. 93: 3444-3449.
41. Wang, L.C., F. Kuo, Y. Fujiwara, D.G. Gilliland, T.R. Golub, and S.H. Orkin. 1997. Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO J. 16: 4374-4383.
42. Yoder, M.C., K. Hiatt, P. Dutt, P. Mukherjee, D.M. Bodine, and D. Orlic. 1997. Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac. Immunity 7: 335-344.
43. Yu, B.D., J.L. Hess, S.E. Horning, G.A.J. Brown, and S.J. Korsmeyer. 1995. Altered Hox expression and segmental identity in Mll-mutant mice. Nature 378: 505-508.
44. Zanjani, E.D., J.L. Ascensao, and M. Tavassoli. 1993. Liver-derived fetal hematopoietic stem cells selectively and preferentially home to fetal bone marrow. Blood 81: 399-404.